Ayurvedic management of Amvata W.S.R. to Rheumatoid Arthitis - A case study
Department of Kayachikitsa, M. A. M.’s Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar, Pune- 411028
Case Study
World Journal of Advanced Research and Reviews, 2022, 16(02), 679-683
Article DOI: 10.30574/wjarr.2022.16.2.1184
Publication history:
Received on 02 October 2022; revised on 15 November 2022; accepted on 17 November 2022
Abstract:
The condition of Amvata was first explained by Madhavkara in Madhav Nidana. Amvata is not only a joint disorder but a disease with systemic involvement, named after its main pathologic constituents ‘Ama’ and ‘Vata’. It is a disorder caused by the impairment of Agni (digestive fire), formation of Ama (bio-toxin) and vitiation of Vata Dosha. Ama combined with Vata Dosha, occupies Shleshmasthana (Asthisandhi) which results in “Amavata”. It is one of the commonest disorders affecting people from the middle age group and is chronic in nature. It can be crippling as it affects the work performance and interferes with day-to-day activities of a person if left untreated. Clinically it can be co-related with Rheumatoid Arthritis (R. A.). Modern medicine doesn’t help in preventing the chronicity of the disorder. Management of R. A. according to modern medicine includes use of NSAID’s (Nonsteroidal anti-inflammatory Drugs), Glucocorticoids, DMARD’s (Disease Modifying Anti Rheumatic Drugs), immunosuppression therapies, for long term. These drugs also cause side effects in most of the patients leading them to discontinue the treatment. Keeping these points in mind, based on the ChikitsaSiddhanta given in Ayurvedic texts, a case of Amvata was treated. Marked improvement was seen in the patient’s signs and symptoms after treatment. No complication or side effect of any drug used was found during the treatment.
Keywords:
Amavata; Rheumatoid Arthritis; SimhanadaGuggulu; Shaman Chikitsa
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0